New Delhi: The approval for Bharat Biotech’s Covaxin for use in the 2-18 years age group may take time before it is made available for people.
The Drugs Controller General of India (DCGI) is carefully examining the recommendation by the expert panel and evaluating several factors, Business Standard reported on Wednesday.
Last week, the panel had recommended the usage of Covaxin for children as young as two. The final approval for 2-18 years old is under expert opinion and evaluation.
The DCGI will hold discussions with the health minister, PMO, and Bharat Biotech before granting EUA to Covaxin, the report quoted sources as saying.
Berhampur: Taking a dig at Bharatiya Janata Party (BJP) for claiming to form government in…
Bhubaneswar: With twin polls less than a week away, the BJP is all set to…
New Delhi: Indian businesswoman and director of the MEIL Group Sudha Reddy graced the red…
Bhubaneswar: With thunderstorm activity accompanied by rain and gusty wind continuing in Odisha, the day…
Bhubaneswar: Biju Janata Dal (BJD) on Tuesday moved Odisha's Chief Electoral Officer (CEO) alleging that…
Bhubaneswar: In a surprise move, BJD nominee for Pipili Assembly seat Rudra Maharathy’s wife Jagruti…
Bhubaneswar: The BJP on Tuesday released a revised list of its 40 star campaigners for…
It’s official now! Odisha FC will represent India in the inaugural edition of the AFC…